FourThought Financial Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
193,062
+11,491
+6% +$1.1M 1.44% 18
2025
Q4
$17.4M Buy
181,571
+2,916
+2% +$283K 1.47% 16
2025
Q3
$17M Sell
178,655
-1,096
-0.6% -$101K 1.5% 14
2025
Q2
$15.7M Buy
179,751
+4,248
+2% +$360K 1.55% 13
2025
Q1
$15.8M Buy
175,503
+43,959
+33% +$3.93M 1.65% 13
2024
Q4
$10.5M Sell
131,544
-40,736
-24% -$3.53M 1.09% 26
2024
Q3
$15.5M Buy
172,280
+6,217
+4% +$523K 1.84% 16
2024
Q2
$13.1M Buy
166,063
+10,639
+7% +$872K 1.68% 18
2024
Q1
$13.5M Buy
155,424
+16,263
+12% +$1.39M 1.55% 14
2023
Q4
$11.5M Sell
139,161
-3,246
-2% -$247K 1.44% 18
2023
Q3
$11.2M Buy
142,407
+4,010
+3% +$336K 1.56% 16
2023
Q2
$12.2M Buy
138,397
+3,371
+2% +$290K 1.6% 13
2023
Q1
$10.9M Buy
135,026
+45,023
+50% +$3.67M 1.49% 16
2022
Q4
$7M Buy
+90,003
New +$7.29M 1.01% 29

Other funds holding MDT

FourThought Financial Partners's MDT Position: Q1 2026 in Review

FourThought Financial Partners increased its Medtronic (MDT) stake by 6.3% in Q1 2026, buying an estimated $1.1M and bringing the position to 193,062 shares worth $16.7M. The position accounts for 1.44% of the portfolio, ranked #18.

FourThought Financial Partners first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $17.4M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • FourThought Financial Partners held 193,062 shares of Medtronic worth $16.7M as of Q1 2026.
  • FourThought Financial Partners bought 11,491 Medtronic shares in Q1 2026, an estimated $1.1M.
  • Medtronic made up 1.44% of FourThought Financial Partners's portfolio in Q1 2026, its #18 holding.
  • FourThought Financial Partners first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
  • FourThought Financial Partners's Medtronic position peaked at $17.4M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.